Telangana: DCA seizes Rs 7-crore spurious drugs worth since July 2023
The Drugs Control Administration (DCA), Telangana, has executed 18 successful operations against illicit pharmacies s...
Source: siasat.com
Lead Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lead Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lead Pharma Today - Breaking & Trending Today
€800K Grant supports Large B-cell Lymphoma Project Labmate Online
Therapeutics developer Lead Pharmaceutical (Oss, Netherlands) and French medicinal chemistry and custom synthesis company Oxeltis, have been awarded an €800K ($842K) grant from EUREKA Eurostars for a three year project aimed at developing a first-in-class small molecule therapy for diffuse large B-cell lymphoma (DLBCL). Click to read more...
Source: labmate-online.com
EUREKA Eurostars grants €0.8 million for immune therapies collaboration
Dutch firm Lead Pharma and French company Oxeltis have been awarded an €800K grant from the 37-nation EUREKA intergovernmental network’s Euro...
Source: labnews.co.uk
Lead Pharma and Oxeltis receive €800K EUREKA Eurostars grant
Grant will fund three-year EPIGENEXT joint project aimed at developing first-in-class therapy for diffuse large B-cell lymphoma Oss, the Netherlands and Montpellier, France, June 8, 2022 – Lead Pharma, a privately held pharmaceutical company designing and developing innovative therapies for the treatment of immune-...
Source: pharmiweb.com
In Silico Drug Discovery Market Share, Size, Industry Analysis, Demand, Growth and Research Report 2020-2028 – KSU
In Silico Drug Discovery Market Share, Size, Industry Analysis, Demand, Growth and Research Report 2020-2028 emergenMay 23, 2021 The global In Silico Drug Discovery Market is forecasted to be worth USD 6.34 Billion by 2027, according to a current analysis by Emergen Research. In November 2020, Lead Pharma announced its collaboration and license agreement with Roche for the development of oral small molecules for the treatment of a broad range of immune-mediated diseases. Lead Pharma is using in silico lab for their computational chemistry, bioinformatics, and data mining activities. The new r...
Source: ksusentinel.com